169 related articles for article (PubMed ID: 2356437)
1. IgG subclass antibody responses to pneumococcal polysaccharide vaccine in splenectomized, otherwise normal, individuals.
Aaberge IS; Michaelsen TE; Heier HE
Scand J Immunol; 1990 Jun; 31(6):711-6. PubMed ID: 2356437
[TBL] [Abstract][Full Text] [Related]
2. IgM and IgG response to pneumococcal polysaccharide vaccine in normal individuals and individuals splenectomized due to trauma.
Aaberge IS; Heier HE; Hem E; Giercksky KE; Groeng EC
Acta Pathol Microbiol Immunol Scand C; 1984 Feb; 92(1):11-6. PubMed ID: 6711306
[TBL] [Abstract][Full Text] [Related]
3. Immune responses of splenectomized trauma patients to the 23-valent pneumococcal polysaccharide vaccine at 1 versus 7 versus 14 days after splenectomy.
Shatz DV; Schinsky MF; Pais LB; Romero-Steiner S; Kirton OC; Carlone GM
J Trauma; 1998 May; 44(5):760-5; discussion 765-6. PubMed ID: 9603075
[TBL] [Abstract][Full Text] [Related]
4. Long-term effect of pneumococcal polysaccharide vaccination on serum IgM and IgG antibody levels in individuals splenectomized for trauma.
Aaberge IS; Heier HE
Acta Pathol Microbiol Immunol Scand C; 1984 Dec; 92(6):363-9. PubMed ID: 6524388
[TBL] [Abstract][Full Text] [Related]
5. Type-specific anti-pneumococcal antibody subclass response to vaccination after splenectomy with special reference to lymphoma patients.
Grimfors G; Björkholm M; Hammarström L; Askergren J; Smith CI; Holm G
Eur J Haematol; 1989 Nov; 43(5):404-10. PubMed ID: 2612613
[TBL] [Abstract][Full Text] [Related]
6. Characterization of specific immunoglobulin G (IgG) and its subclasses (IgG1 and IgG2) against the 23-valent pneumococcal vaccine in a healthy adult population: proposal for response criteria.
Rodrigo MJ; Miravitlles M; Cruz MJ; de Gracia J; Vendrell M; Pascual C; Morell F
Clin Diagn Lab Immunol; 1997 Mar; 4(2):168-72. PubMed ID: 9067650
[TBL] [Abstract][Full Text] [Related]
7. IgG and IgM antibody responses to pneumococcal vaccination in splenectomized children and in children who had non-operative management of splenic rupture.
Kalin M; Linné T; Eriksson M; Lännergren K; Tordal P; Jakobsson B; Lundmark KM
Acta Paediatr Scand; 1986 May; 75(3):452-6. PubMed ID: 3728005
[TBL] [Abstract][Full Text] [Related]
8. Assignment of weight-based immunoglobulin G1 (IgG1) and IgG2 units in antipneumococcal reference serum lot 89-S(F) for pneumococcal polysaccharide serotypes 1, 4, 5, 7F, 9V, and 18C.
Sikkema DJ; Ziembiec NA; Jones TR; Hildreth SW; Madore DV; Quataert SA
Clin Diagn Lab Immunol; 2005 Jan; 12(1):218-23. PubMed ID: 15643011
[TBL] [Abstract][Full Text] [Related]
9. Serum antibody responses to vaccination with 23-valent pneumococcal vaccine in splenectomized patients.
Reinert RR; Kaufhold A; Kühnemund O; Lütticken R
Zentralbl Bakteriol; 1994 Nov; 281(4):481-90. PubMed ID: 7727895
[TBL] [Abstract][Full Text] [Related]
10. Antibody response to pneumococcal vaccine in splenectomized children.
Pedersen FK
Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):169-80. PubMed ID: 6880749
[TBL] [Abstract][Full Text] [Related]
11. Post-immunization pneumococcal antibody titers and IgG subclasses.
Sorensen RU; Hidalgo H; Moore C; Leiva LE
Pediatr Pulmonol; 1996 Sep; 22(3):167-73. PubMed ID: 8893255
[TBL] [Abstract][Full Text] [Related]
12. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
[TBL] [Abstract][Full Text] [Related]
13. Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide.
Musher DM; Luchi MJ; Watson DA; Hamilton R; Baughn RE
J Infect Dis; 1990 Apr; 161(4):728-35. PubMed ID: 2319166
[TBL] [Abstract][Full Text] [Related]
14. Prevention of pneumococcal bacteremia by immunization with type 6 pneumococcal capsular polysaccharide vaccine in splenectomized rats.
Iinuma H; Okinaga K
J Infect Dis; 1989 Jul; 160(1):66-75. PubMed ID: 2732517
[TBL] [Abstract][Full Text] [Related]
15. Time course of antibody response to tetanus toxoid and pneumococcal capsular polysaccharides in patients infected with HIV.
Talesnik E; Vial PA; Labarca J; Méndez C; Soza X
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(5):471-7. PubMed ID: 9859960
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin classes and persistence of anti-pneumococcal antibodies in splenectomized adults and adolescents after pneumococcal vaccination.
Pedersen FK; Nielsen JL; Ellegaard J
Acta Pathol Microbiol Immunol Scand C; 1983 Aug; 91(4):245-9. PubMed ID: 6637480
[TBL] [Abstract][Full Text] [Related]
17. Serum antibodies to pneumococcal C polysaccharide in children: response to acute pneumococcal otitis media or to vaccination.
Koskela M
Pediatr Infect Dis J; 1987 Jun; 6(6):519-26. PubMed ID: 3615065
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin G class and subclass antibodies to pneumococcal capsular polysaccharides.
Chudwin DS; Artrip SG; Schiffman G
Clin Immunol Immunopathol; 1987 Jul; 44(1):114-21. PubMed ID: 3297436
[TBL] [Abstract][Full Text] [Related]
19. Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines.
O'Brien KL; Steinhoff MC; Edwards K; Keyserling H; Thoms ML; Madore D
Pediatr Infect Dis J; 1996 May; 15(5):425-30. PubMed ID: 8724065
[TBL] [Abstract][Full Text] [Related]
20. IgG2 subclass restriction of antibody to pneumococcal polysaccharides.
Barrett DJ; Ayoub EM
Clin Exp Immunol; 1986 Jan; 63(1):127-34. PubMed ID: 3955880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
